Boston Scientific (HAM:BSX) Other Stockholders Equity: €-266 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAM:BSX Boston Scientific Corp HAM:BSX
80 GF Score
Price €37.14
GF Value €91.57
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Boston Scientific Other Stockholders Equity?

Boston Scientific HAM:BSX -1.05% 80 Other Stockholders Equity is €-266 Mil as of Jun. 2026. GuruFocus rates HAM:BSX with a GF Score™ of 80/100 and a GF Value™ of €91.57 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Boston Scientific's Other Stockholders Equity for the quarter that ended in Jun. 2026 was €-266 Mil.

Boston Scientific's quarterly Other Stockholders Equity increased from Dec. 2025 (€-519 Mil) to Mar. 2026 (€-345 Mil) and increased from Mar. 2026 (€-345 Mil) to Jun. 2026 (€-266 Mil).

Boston Scientific's annual Other Stockholders Equity increased from Dec. 2023 (€45 Mil) to Dec. 2024 (€266 Mil) but then declined from Dec. 2024 (€266 Mil) to Dec. 2025 (€-519 Mil).

Boston Scientific Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Boston Scientific's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific Other Stockholders Equity Chart

Boston Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 231.27 251.11 45.26 265.57 -518.54

Boston Scientific Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -615.07 -587.23 -518.54 -345.43 -265.90
HAM:BSX
80GF Score
Boston Scientific Corp HAM:BSX
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boston Scientific Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-266 Mil mean?
Boston Scientific (HAM:BSX) has a Other Stockholders Equity of €-266 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Boston Scientific and its competitors.
Is Boston Scientific's Other Stockholders Equity too high?
Boston Scientific's current Other Stockholders Equity is €-266 Mil. Overall, Boston Scientific has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Other Stockholders Equity compare to EW and DXCM?
Boston Scientific's Other Stockholders Equity of €-266 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Boston Scientific and its competitors. Boston Scientific's current Other Stockholders Equity is €-266 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (HAM:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is €91.57, compared to a current price of €37.14 — trading 59.4% below its estimated fair value. The current Other Stockholders Equity is €-266 Mil. Boston Scientific's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Boston Scientific (HAM:BSX), the current Other Stockholders Equity is €-266 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (HAM:BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of €37.14 is trading 59.4% below its estimated GF Value™ of €91.57. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for HAM:BSX:

  • Other Stockholders Equity: €-266 Mil
  • GF Value™: €91.57 vs. price of €37.14 (59.4% below fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the HAM:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific Corp is a medical device manufacturer that develops minimally invasive technologies used across a range of clinical specialties. Its portfolio spans cardiology, including interventional cardiology, cardiac rhythm management, electrophysiology, and structural heart devices; peripheral interventions; endoscopy; urology and pelvic health; and neuromodulation for chronic pain and movement disorders. The company also produces devices for interventional oncology and gastrointestinal diagnostics. Boston Scientific sells primarily to hospitals, healthcare systems, clinics, and physicians worldwide, generating revenue through direct sales and a network of distributors. It operates across the United States, Europe, Asia-Pacific, Latin America, and other international markets, with a substantial and growing share of revenue coming from outside the United States. The company invests heavily in research and development and frequently expands through acquisitions of complementary device makers and technologies.
80GF Score

Get the complete analysis for HAM:BSX

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€37.14
Price
€91.57
GF Value